AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglihop-MG 2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Anax Lifescience

Salt Composition

Glimepiride (NA) + Metformin (NA) + Voglibose (NA)

Overview Voglihop-MG 2 Tablet SR

Diabetol-Duo 2mg Extended-Release tablets are classified as antidiabetic medications. This combination therapy is indicated for adult management of type 2 diabetes mellitus. It effectively regulates blood glucose in diabetic patients. Diabetol-Duo 2mg Extended-Release should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating a balanced diet, regular exercise, and weight management as recommended by your doctor. Lifestyle modifications significantly impact diabetes control. The most prevalent adverse effect of Diabetol-Duo 2mg Extended-Release is hypoglycemia (low blood sugar). Learn to recognize its symptoms—sweating, dizziness, headache, and tremors—and how to manage them. Regular meals and readily available glucose sources (sugary snacks or juice) are essential. Alcohol consumption should be limited due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Voglihop-MG 2 Tablet SR

There is no text provided to rephrase.

Uses of Voglihop-MG 2 Tablet SR

Managing type 2 diabetes

Major Benefits of Voglihop-MG 2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglihop-MG 2 Tablet SR on an empty stomach.

Common Side effects of Voglihop-MG 2 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglihop-MG 2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Voglihop-MG 2 Tablet SR. Ingest the tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.

How Voglihop-MG 2 Tablet SR works:

The extended-release tablet, Voglihop-MG 2 SR, contains a triple-drug formulation to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Voglihop-MG 2 Tablet SR use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglihop-MG 2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Voglihop-MG 2 Tablet may pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, with consequent potential harm to the nursing child.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyUNSAFE

Employing Voglihop-MG 2 Tablet SR carries a high likelihood of risk for individuals with impaired kidney function and is best avoided. Medical advice is recommended. Furthermore, its use is contraindicated in patients exhibiting severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Voglihop-MG 2 Tablet SR cautiously, potentially requiring dose modification. Severe hepatic dysfunction contraindicates its use; a low starting dose is advised for those with mild to moderate liver disease. Physician consultation is recommended.

What if you forget to take Voglihop-MG 2 Tablet SR :

Should you forget a dose of Voglihop-MG 2 Tablet SR, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Voglihop-MG 2 Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Voglihop-MG 2 Tablet SR

Voglihop-MG 2 Tablet SR combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This therapy enhances blood glucose control when coupled with a suitable diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and augments insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal glucose levels. This formulation is unsuitable for type 1 diabetes mellitus.
Taking Voglihop-MG 2 Tablet SR may cause common side effects including low blood sugar, nausea, diarrhea, changes in taste perception, gas, abdominal pain, headache, skin eruptions, and respiratory illness.
Patients with hypersensitivity to Voglihop-MG 2 Tablet SR constituents or inactive ingredients should not take this medication. Similarly, its administration is contraindicated in individuals with moderate to severe nephropathy, inflammatory bowel disorders, colonic ulcers, and underlying metabolic acidosis, encompassing diabetic ketoacidosis.
Combining Voglihop-MG 2 Tablet SR and alcohol is unsafe. This combination can lead to dangerously low blood sugar and a heightened risk of lactic acidosis.
Indeed, Voglihop-MG 2 Tablet SR can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. This risk increases with skipped or delayed meals, alcohol consumption, strenuous activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Voglihop-MG 2 Tablet SR
86
MRP 105
18% off